Suja Life priced its Nasdaq IPO at $21 per share Thursday, selling 8.9 million shares and raising $186.9 million before fees. The Costa Mesa cold-pressed juice and functional beverage maker enters public markets at a $1.03 billion pre-money valuation, marking one of the few venture-backed consumer packaged goods exits this quarter.
The deal prices at the top of Suja's filed range, last revised upward in December filings. Goldman Sachs and J.P. Morgan led the book. Suja's backers include Encore Consumer Capital, Paine Schwartz Partners, and Coca-Cola's venture arm, which seeded the brand in 2015 but later reduced its stake. The company posted $287 million in trailing revenue with a 19% EBITDA margin, according to amended S-1 disclosures. Gross margin held at 42% despite freight inflation and co-packing cost creep through fiscal 2024. Whole Foods and Costco represent 61% of distribution, a concentration the prospectus flags as material risk.
The IPO matters because it tests whether public investors will pay venture multiples for subscription-vulnerable wellness brands. Suja's revenue multiple at pricing sits near 3.6x, above the median 2.8x for food and beverage IPOs since 2022 but below the 4.2x average wellness brands commanded in 2020 and 2021. The Coca-Cola venture linkage offers some moat, but not exclusivity. Competitors PepsiCo-backed Poppi and Red Bull's Organics line already hold premium chilled shelf space, and private label cold-pressed SKUs now appear in Target and Kroger at 40% lower price points. Suja's differentiation hinges on its high-pressure processing tech and USDA organic cert across 94% of SKUs, but margin defense will depend on whether it can hold pricing power as private equity rolls up adjacent brands.
Operators should watch Suja's first two quarterly prints for any erosion in Whole Foods velocity or Costco re-order cadence. The company guided to 12-15% revenue growth in 2025, but that assumes flat retailer door count and no meaningful Amazon Fresh or Instacart cannibalization. If Suja holds $21 or trades up, expect two to three dormant functional beverage IPOs to refile by March. If it breaks below $19 in the first month, venture-backed CPG exits will tilt further toward trade sale rather than public listing. Paine Schwartz owns 31% post-IPO and faces a 180-day lockup, so any secondary overhang likely surfaces in Q3.
The wellness category has not produced a durable public pure-play since Vital Farms in 2020. Suja's organic cert and Costco traction give it better odds than most, but the $1 billion valuation requires flawless execution on a model where the largest customers also control the margin.